Ophtalmopharma ^Company

OphthalmoPharma (OPPH) is a pharmaceutical company that focuses on developing treatments for eye-related medical conditions such as dry eye syndrome, glaucoma, and age-related macular degeneration. They have granted Altacor exclusive rights for their two therapeutic products for glaucoma and dry eye, EyeBar nutraceutical, and preloaded injector for intraocular lens delivery in cataract and corrective lens replacement surgery.